Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |